JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB56270

Recombinant Human Rb protein

Be the first to review this product! Submit a review

|

(4 Publications)

Recombinant Human Rb protein is a Human Fragment protein, in the 773 to 928 aa range, expressed in Escherichia coli, with >85%, suitable for SDS-PAGE, FuncS.

View Alternative Names

Retinoblastoma-associated protein, p105-Rb, p110-RB1, pRb, pp110, Rb, RB1

1 Images
SDS-PAGE - Recombinant Human Rb protein (AB56270)
  • SDS-PAGE

Unknown

SDS-PAGE - Recombinant Human Rb protein (AB56270)

ab56270 on SDS-PAGE.

Key facts

Purity

>85% Densitometry

Expression system

Escherichia coli

Tags

GST tag N-Terminus

Applications

FuncS, SDS-PAGE

applications

Biologically active

No

Accession

P06400

Animal free

No

Carrier free

No

Species

Human

Storage buffer

pH: 7.5 Constituents: 25% Glycerol (glycerin, glycerine), 0.87% Sodium chloride, 0.79% Tris HCl, 0.00385% (R*,R*)-1,4-Dimercaptobutan-2,3-diol, 0.00174% PMSF

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "FuncS": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p>This product is used as a substrate for <a href='/en-us/products/proteins-peptides/recombinant-human-cdk4-ccnd3-protein-ab85646'>ab85646</a></p>" } } }

Product details

ab56270 (Human Rb protein fragment) can be utilized as a substrate for the following active protein Kinases:

ab55695 (Human Cdk4 + Cyclin D1 full length protein)
ab84557 (Active human CDK6 + CCND3 full length protein)
ab84559 (Active human CDK6 + CCND1 full length protein)

ab85646 (Active human CDK4 + CCND3 full length protein)

ab177576 (Active human PFTK1 (CDK14)/CyclinY full length protein)

ab177586 (Active human PCTAIRE1 protein fragment)

Sequence info

[{"linker":null,"sequence":"","proteinLength":"Fragment","predictedMolecularWeight":null,"actualMolecularWeight":null,"aminoAcidEnd":928,"aminoAcidStart":773,"nature":"Recombinant","expressionSystem":null,"accessionNumber":"P06400","tags":[{"tag":"GST","terminus":"N-Terminus"}]}]

Properties and storage information

Form
Liquid
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-80°C
Appropriate long-term storage conditions
-80°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
False

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Retinoblastoma protein (Rb) also known as pRb is an important regulatory protein with a molecular weight of approximately 110 kDa. It is mainly expressed in the nucleus of cells. Rb functions as a tumor suppressor by controlling the cell cycle progression from G1 to S phase. Rb becomes active when it is dephosphorylated allowing it to bind and inhibit E2F transcription factors consequently preventing the transcription of genes essential for S phase entry.
Biological function summary

Retinoblastoma protein influences cellular proliferation differentiation and apoptosis. It acts within a larger protein complex modulating various cellular responses. When functional Rb halts uncontrolled cell division important for maintaining normal tissue homeostasis. In its phosphorylated state known as phospho-Rb or phospho-Rb E182 it loses its regulatory capabilities which can lead to unrestrained cell cycle progression.

Pathways

Several involve the retinoblastoma protein. One key pathway is the p53 pathway which Rb interacts with to influence cellular outcomes like cell-cycle arrest and apoptosis. Rb cooperates with proteins like p21 to implement these processes. Additionally it is involved in the cyclin D-dependent kinase 4 (CDK4) pathway which modulates its phosphorylation state influencing binding interactions and cell cycle control.

Dysregulation of retinoblastoma protein is commonly associated with cancer particularly retinoblastoma and breast cancer. In retinoblastoma mutations in the Rb gene directly lead to uncontrolled cell proliferation due to the absence of functional Rb protein. Additionally Rb's connection to the E2F family of transcription factors can become disrupted contributing to oncogenesis in other cancers.

General info

Function

Tumor suppressor that is a key regulator of the G1/S transition of the cell cycle (PubMed : 10499802). The hypophosphorylated form binds transcription regulators of the E2F family, preventing transcription of E2F-responsive genes (PubMed : 10499802). Both physically blocks E2Fs transactivating domain and recruits chromatin-modifying enzymes that actively repress transcription (PubMed : 10499802). Cyclin and CDK-dependent phosphorylation of RB1 induces its dissociation from E2Fs, thereby activating transcription of E2F responsive genes and triggering entry into S phase (PubMed : 10499802). RB1 also promotes the G0-G1 transition upon phosphorylation and activation by CDK3/cyclin-C (PubMed : 15084261). Directly involved in heterochromatin formation by maintaining overall chromatin structure and, in particular, that of constitutive heterochromatin by stabilizing histone methylation. Recruits and targets histone methyltransferases SUV39H1, KMT5B and KMT5C, leading to epigenetic transcriptional repression. Controls histone H4 'Lys-20' trimethylation. Inhibits the intrinsic kinase activity of TAF1. Mediates transcriptional repression by SMARCA4/BRG1 by recruiting a histone deacetylase (HDAC) complex to the c-FOS promoter. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex (By similarity).. (Microbial infection) In case of viral infections, interactions with SV40 large T antigen, HPV E7 protein or adenovirus E1A protein induce the disassembly of RB1-E2F1 complex thereby disrupting RB1's activity.

Sequence similarities

Belongs to the retinoblastoma protein (RB) family.

Post-translational modifications

Phosphorylated by CDK6 and CDK4, and subsequently by CDK2 at Ser-567 in G1, thereby releasing E2F1 which is then able to activate cell growth. Dephosphorylated at the late M phase. SV40 large T antigen, HPV E7 and adenovirus E1A bind to the underphosphorylated, active form of pRb. Phosphorylation at Thr-821 and Thr-826 promotes interaction between the C-terminal domain C and the Pocket domain, and thereby inhibits interactions with heterodimeric E2F/DP transcription factor complexes. Dephosphorylated at Ser-795 by calcineruin upon calcium stimulation. CDK3/cyclin-C-mediated phosphorylation at Ser-807 and Ser-811 is required for G0-G1 transition. Phosphorylated by CDK1 and CDK2 upon TGFB1-mediated apoptosis.. N-terminus is methylated by METTL11A/NTM1 (By similarity). Monomethylation at Lys-810 by SMYD2 enhances phosphorylation at Ser-807 and Ser-811, and promotes cell cycle progression. Monomethylation at Lys-860 by SMYD2 promotes interaction with L3MBTL1.. Acetylated during keratinocyte differentiation. Acetylation at Lys-873 and Lys-874 regulates subcellular localization. Can be deacetylated by SIRT1.

Subcellular localisation

Nucleus

Product protocols

Target data

Tumor suppressor that is a key regulator of the G1/S transition of the cell cycle (PubMed : 10499802). The hypophosphorylated form binds transcription regulators of the E2F family, preventing transcription of E2F-responsive genes (PubMed : 10499802). Both physically blocks E2Fs transactivating domain and recruits chromatin-modifying enzymes that actively repress transcription (PubMed : 10499802). Cyclin and CDK-dependent phosphorylation of RB1 induces its dissociation from E2Fs, thereby activating transcription of E2F responsive genes and triggering entry into S phase (PubMed : 10499802). RB1 also promotes the G0-G1 transition upon phosphorylation and activation by CDK3/cyclin-C (PubMed : 15084261). Directly involved in heterochromatin formation by maintaining overall chromatin structure and, in particular, that of constitutive heterochromatin by stabilizing histone methylation. Recruits and targets histone methyltransferases SUV39H1, KMT5B and KMT5C, leading to epigenetic transcriptional repression. Controls histone H4 'Lys-20' trimethylation. Inhibits the intrinsic kinase activity of TAF1. Mediates transcriptional repression by SMARCA4/BRG1 by recruiting a histone deacetylase (HDAC) complex to the c-FOS promoter. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex (By similarity).. (Microbial infection) In case of viral infections, interactions with SV40 large T antigen, HPV E7 protein or adenovirus E1A protein induce the disassembly of RB1-E2F1 complex thereby disrupting RB1's activity.
See full target information RB1

Publications (4)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 12:6667 PubMed34795269

2021

HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Alison E Smith,Emanuela Ferraro,Anton Safonov,Cristina Bernado Morales,Enrique J Arenas Lahuerta,Qing Li,Amanda Kulick,Dara Ross,David B Solit,Elisa de Stanchina,Jorge Reis-Filho,Neal Rosen,Joaquín Arribas,Pedram Razavi,Sarat Chandarlapaty

Cancer discovery 12:356-371 PubMed34544752

2021

INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors.

Applications

Unspecified application

Species

Unspecified reactive species

Qing Li,Baishan Jiang,Jiaye Guo,Hong Shao,Isabella S Del Priore,Qing Chang,Rei Kudo,Zhiqiang Li,Pedram Razavi,Bo Liu,Andrew S Boghossian,Matthew G Rees,Melissa M Ronan,Jennifer A Roth,Katherine A Donovan,Marta Palafox,Jorge S Reis-Filho,Elisa de Stanchina,Eric S Fischer,Neal Rosen,Violeta Serra,Andrew Koff,John D Chodera,Nathanael S Gray,Sarat Chandarlapaty

Nature communications 10:558 PubMed30718512

2019

CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary.

Applications

Unspecified application

Species

Unspecified reactive species

Yibo Xue,Brian Meehan,Elizabeth Macdonald,Sriram Venneti,Xue Qing D Wang,Leora Witkowski,Petar Jelinic,Tim Kong,Daniel Martinez,Geneviève Morin,Michelle Firlit,Atefeh Abedini,Radia M Johnson,Regina Cencic,Jay Patibandla,Hongbo Chen,Andreas I Papadakis,Aurelie Auguste,Iris de Rink,Ron M Kerkhoven,Nicholas Bertos,Walter H Gotlieb,Blaise A Clarke,Alexandra Leary,Michael Witcher,Marie-Christine Guiot,Jerry Pelletier,Josée Dostie,Morag Park,Alexander R Judkins,Ralf Hass,Douglas A Levine,Janusz Rak,Barbara Vanderhyden,William D Foulkes,Sidong Huang

Journal of cell science 124:2175-86 PubMed21652635

2011

Knockdown of Fbxo7 reveals its regulatory role in proliferation and differentiation of haematopoietic precursor cells.

Applications

BL

Species

Unspecified reactive species

El Kahina Meziane,Suzanne J Randle,David E Nelson,Mikhail Lomonosov,Heike Laman
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com